The increased PL and decreased EPL levels in Pex3+/– D4M.3a cells are consistent with clinical phenotypes detected in patients with peroxisomal disorders and corresponding PEX3 biallelic mutant cell lines in vitro (28–30). This evidence concerns the gene PEX3 and peroxisomal disease.